NeurosciencebioRxivPreprint
CCR2-targeting pepducins reduce T cell-nociceptor interaction driving bone cancer pain
Élora Midavaine, Rebecca L. Brouillette, Élizabeth Théberge…·Philippe Sarret
The paper shows that CCR2-targeting pepducin PP101 reduces bone cancer pain by inhibiting T cell infiltration and neuroimmune communication in dorsal root ganglia without adverse effects.
1 citation